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A B S T R A C T
Purpose: Previous studies showed that a single oral administration of a synthetic ketone ester (1,3-
butanediol acetoacetate diester, BD-AcAc2) could elevate blood ketones with promising acute anti-
epileptic effects. The aim of the present work was to evaluate the tolerability of a prolonged
administration of BD-AcAc2 and the anti-epileptic efﬁcacy of such treatment.
Methods: The threshold for seizure induction with progressive intravenous infusion of pentylenetrazole
(PTZ) was evaluated in anesthetized Wistar rats after a ten-day oral administration of BD-AcAc2
(gavage). The effects of this treatment were compared to those of: (1) a ten-day water gavage
administration, (2) a ten-day ketogenic diet, (3) a standard rodent chow diet.
Results: Compared to the standard diet, all other treatments produced a calorie restriction and an
elevation of the seizure threshold.
Conclusion: These results indicate that supplementation with an oral synthetic ketone can have anti-
seizure effects, but the formulation has to be further ameliorated to be more palatable; further studies
are also needed to better understand the role played by ketone bodies alone in vivo, without any calorie
restriction.
 2016 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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The ketogenic diet (KD) is acknowledged for its anti-epileptic
efﬁcacy, although its mechanism of action is poorly understood
[1,2]. One hypothesis has been that ketone bodies, typically
increased during a KD, can have an anti-epileptic effect.
Accordingly, in previous studies it has been shown that a single
oral administration of a synthetic ketone ester (1,3-butanediol
acetoacetate diester, BD-AcAc2) had promising acute anti-seizure
effects, as assessed by a hyperbaric-induced convulsion model [3]
or by a pentylenetetrazole (PTZ)-induced seizure ﬁring in* Corresponding author at: Department of Medicine and Surgery, University of
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1059-1311/ 2016 British Epilepsy Association. Published by Elsevier Ltd. All rights reanesthetized rats [4]. These results suggest that a ‘‘ketogenic diet
in a pill’’ could be possible [5]. On the other hand, it has been shown
that the efﬁcacy of KD is dependent on age and calorie restriction
[6], thus it is questioned how much the anti-epileptic effect of KD
can be ascribed to ketone bodies alone.
The aim of the present work was to evaluate the tolerability and
the anti-seizure efﬁcacy of a prolonged administration of BD-AcAc2
in the PTZ-model, comparing this effect with that of a calorie-
restricted KD.
2. Materials and methods
2.1. Animals
Twenty male Wistar rats (Harlan Laboratories, Udine, Italy),
weighting 150  15 g (mean  S.D.), were randomly divided into
four groups. Rats were housed in standard temperature and humidityserved.
Fig. 1. (A) Time sequence of the experimental protocol. Infusion was stopped when
a sustained seizure discharge was present. (B) Examples of cEEG recordings from a
no-gavage/standard diet-fed rat (control) and from a KD-fed treated rat. The start of
the PTZ injection is marked with the longer arrows; PTZ was injected with a
constant rate of 25 mg/min. The PTZ-threshold was evaluated as the time between
PTZ infusion start (longer arrows) and the time of the ﬁrst spike indicating a seizure-
like ﬁring (short arrows); this spike was deﬁned as having an amplitude greater
than 0.5 mV (in both positive and negative phases) and with an inter-peak latency
shorter than 1 s. In these particular examples, the PTZ dose injected until the above
deﬁned PTZ-threshold were 40 mg/kg b.w. for the control rat and 112 mg/kg b.w.
for the KD-fed rat.
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07:00 p.m.). Animals belonging to groups 1, 2 and 3 were given free
access to standard food and tap water. Animals belonging to group
4 were, instead, given an anti-epileptic calorie-restricted KD [6]. All
procedures fulﬁlled the requirements of the ‘‘Guide for the Care and
Use of Laboratory Animals‘’ released by the National Research Council
and implemented by EU and local rules. Animals were kept under
general anesthesia with urethane during all surgical procedures and
seizure induction; the research was approved by the local ethical
committee of the University of Salerno and by the Ministry of Health
of the Italian Government.
2.2. Pre-treatment
Animals of group 1 and group 2 were fed with a standard diet
and were given by gavage 1 ml of water (group 1) or BD-AcAc2
(group 2) two times per day (at 09:30 a.m. and at 04:00 p.m.) for
ten days. This dose was chosen because previous studies
demonstrated that 1 ml of BD-AcAc2 has acute anti-seizure
effects [4]; the dose was administered twice daily because the
elevation in blood ketones does not last more than 8 h
(unpublished data). Details on BD-AcAc2 synthesis are reported
elsewhere [3]. Rats of group 3 were not given any gavage and
received a standard diet. Rats of group 4 were not given any gavage
but were fed with a calorie-restricted KD that has a well
documented anti-seizure effect [6]; brieﬂy, each day they were
given approximately 90% of the calculated daily calorie require-
ment by a food mix composed of more than 78% fat (Bio-Serv
cF3666, Frenchtown, NJ, USA).
Body weights were recorded every day. Blood glucose (Gluco-
Men LX plus, Menarini Diagnostics, Firenze, Italy) and blood
ketones in the form of b-hydroxybutyrate (bHB; Freestyle Optium,
Abbott, Rome, Italy) were recorded on day 0 (start of treatment),
and on days 2, 5 and 7; blood drops were obtained by tail prick at
09:00 a.m. (before the morning gavage).
Possible neurotoxic effects were evaluated in all rats on days 0,
3 and 8 through ﬁve behavioral tests, as described by Swinyard
et al. [7]: positional sense test, righting-reﬂex test, gait-and-
stance test, muscle tone, equilibrium. For each test a score of 0
(failed), 1 (positive) or 2 (quick response) was assigned, thus the
total score (i.e. the sum of the scores from the 5 tests) could range
from 0 to 10.
2.3. Surgery
On the day of the experiment, weight, blood glucose and blood
ketones were again recorded for each rat and a gavage of 1 ml of
water (group 1) or BD-AcAc2 (group 2) was administered. Thirty
minutes after the gavage, rats were anesthetized with 1.5 g/kg b.w.
of urethane (Sigma–Aldrich, Milano, Italy); rats from group 3
(standard diet) and group 4 (KD) were anesthetized without
gavage. From this time until the end of the experiment, body
temperature was maintained at 36.5  0.5 8C with a thermostated
heating pad. The femoral vein was then accessed by inguinal incision
and insertion of a polyethylene catheter (outer diameter 0.6 mm) to a
depth of 6 cm. Placement of electrodes to record cortical-electroen-
cephalogram (cEEG) was achieved by percutaneous incision of the
scalp and osteotomy of the calvarium. Two holes (1.4 mm in
diameter) were drilled on the skull at the following coordinates:
ﬁrst hole at 2 mm lateral from midline and 2 mm anterior from
bregma; second hole at 2 mm lateral from midline and 2 mm
posterior from bregma. Two stainless steel screws (1.6 mm in
diameter; Novara Metalli, Novara, Italy) were placed into these holes
at a depth of 2 mm from the skull surface and served as recording
electrodes. A safety pin, the reference electrode, was placed
subcutaneously in the posterior of the neck.2.4. cEEG recording
The recording and reference electrodes were connected to a
custom made digital ampliﬁer [8], which provided a gain of 5000 v/
v, a band pass ﬁlter from 1.6 Hz to 100 Hz and an analog-to-digital
conversion with a resolution of 12 bits and a sampling frequency of
1000 samples/s. The ampliﬁer sent the digital readings to a PC
through a standard USB port; a custom software written with
LabView (National Instruments, Austin, Texas, USA) provided real
time visualization and recording of the cEEG for subsequent
analysis and allowed manual marking of the events of interest (e.g.
perfusion start and perfusion stop).
At 1 h:00 min after the anesthesia, cEEG recording was started.
At 1 h:30 min after the anesthesia, when BD-AcAc2 gavage has the
maximum effect on blood bHB levels [3], the femoral catheter was
connected to a syringe-pump preﬁlled with 100 mg/ml of PTZ
(Sigma–Aldrich, Milano, Italy), and PTZ infusion was started at a
rate of 0.25 ml/min. When a sustained high frequency and high
amplitude seizure discharge was evident (greater than 0.5 mV
from the zero level of the signal and lasting more than 5 s), the
infusion was interrupted and recording was maintained for
another 30 min. The protocol time sequence is summarized in
Fig. 1A.
For each cEEG recording, the onset-time of the seizure discharge
was measured, deﬁned as the time from the infusion start to the
ﬁrst of the above-threshold peaks; above-threshold peaks were
Fig. 3. Mean blood bHB level from all experimental groups. Values were taken at
morning, before any gavage, thus showing the minimal levels produced by the
treatments. Only the KD group had signiﬁcantly high blood ketone levels. Asterisks
indicate statistical signiﬁcant difference compared to other groups at that time
point (P < 0.05).
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peak latency time lower than 1 s (Fig. 1B). For each rat, the PTZ-
threshold for seizure induction was deﬁned as the injected dose of
PTZ at the onset-time of the seizure discharge (mg/kg b.w.).
2.5. Histological controls
At the end of the seizure recording procedures, rats were
sacriﬁced by anesthetic overdose. Liver, kidney and stomach were
immediately removed and stored in 4% formaldehyde/phosphate
buffer solution. Tissues were processed by routine histological
procedures and stained with hematoxilin/eosin.
2.6. Statistical analysis
Data are expressed as mean  S.E. Statistically signiﬁcant
differences were evaluated by the analysis of variance (ANOVA) for
repeated measures; post hoc test – multiple comparisons were
performed with the Tuke’s test.
3. Results
3.1. Body weight
All groups differed from each other when compared for body
weight gain (Fig. 2); compared to the no-gavage/standard diet-fed
group (group 3), all other groups showed a strong impairment in
body weight gain. The grading for the weight gain of the
treatments was BD-AcAc2-gavage < water gavage < KD <<
standard diet. The ANOVA for repeated measures demonstrated
a signiﬁcant effect for the treatment (F3,144 = 2011, P < 0.01), for
the time (F8,144 = 10, P < 0.01) and for the treatment  time
interaction (F24,144 = 292, P < 0.02). Multiple comparisons showed
that all groups differed from each other from day 3 to day 9, except
for the comparison water-gavage group – KD group which was
signiﬁcant from day 6 to day 9 (P < 0.05).
3.2. Blood glucose
All blood glucose values were within the normal range
(100  25 mg/100 ml) and there were no signiﬁcant differences
between groups.
3.3. Blood bHB
As expected, the KD-group showed higher blood bHB values
than those observed in the controls (Fig. 3); all other groups
showed normal low values for blood bHB with no signiﬁcant
differences between them. The ANOVA for repeated measuresFig. 2. Mean weight trends of the experimental groups. Values are expressed as the
percentage of weight at day 0. All groups differed from each other from day 3 to day
9, except for the comparison water-gavage group – KD group, which was signiﬁcant
from day 6 to day 9 (P < 0.05).showed a signiﬁcant effect for the treatment (F3,64 = 37, P < 0.01)
and for the treatment  time interaction (F9,64 = 4.2, P < 0.01). The
post hoc test demonstrated a signiﬁcant difference between the
KD-treated group and all other groups (P < 0.05).
3.4. Behavioral tests
No rat failed any behavioral test at any time point. No
statistically signiﬁcant difference was seen for the total score
between the experimental groups.
3.5. Seizure PTZ-threshold
Compared to the no-gavage/standard diet group, all other
groups showed a higher PTZ-threshold (Fig. 4). The ANOVA showed
a signiﬁcant difference between groups (F3,16 = 5.02, P < 0.02). The
post hoc test demonstrated a signiﬁcant difference between the
no-gavage/standard diet group and all other groups; there were no
signiﬁcant differences between the KD group, the BD-AcAc2 group
and the water-gavage group (Fig. 4).
3.6. Histological controls
Morphological ﬁndings were mostly normal for all the organs.
Some renal peri-tubular blood extravasations were observed in
one rat from the BD-AcAc2-treated group and in two rats from the
water-treated group. A tubular necrosis and a partial glomerular
sclerosis were also observed in another rat from the BD-AcAc2-
treated group (Fig. 5).Fig. 4. Mean seizure PTZ-threshold obtained from each experimental group. All
treatments resulted in a higher threshold compared to the no-gavage/standard
diet-fed group (control). The asterisk indicates statistical signiﬁcant difference
compared to other groups (P < 0.05).
Fig. 5. Kidney histological control. (A) A blood extravasation (arrow) in the medulla detected in one BD-AcAc2-treated rat. The same was observed in two water treated rats.
(B) A glomerular sclerosis (long arrow) and tubular necrosis (point arrow) were seen in a BD-AcAc2-treated rat.
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The results from the present experiments demonstrated that
many different treatments causing a calorie restriction can also
produce an anti-seizure effect when evaluated with the anesthe-
tized PTZ-model. In fact, even a water gavage treatment, which
resulted in growth retardation (Fig. 2) probably due to stress from
manipulation and decreased food intake, resulted in an increased
seizure PTZ-threshold compared to control animals to an extent
comparable to that obtained with a KD (Fig. 4). This result does not
support a major role for ketone bodies in an anti-seizure effect,
because three very different treatments produced a comparable
anti-seizure affect (KD, water gavage, BD-AcAc2 gavage), but only
the KD treatment resulted in a signiﬁcant increase in blood
ketones. Nevertheless, an effect of ketone bodies cannot be
excluded, because even in humans just a restricted diet (or
fasting) with water contributes to ketosis and is frequently used
before initiating a KD. Moreover, at present we failed to obtain an
increase in blood ketones without a signiﬁcant calorie restriction;
further attempts should be made to obtain this condition, thus
evaluating the anti-seizure efﬁcacy of ketone bodies alone in vivo.
To better test BD-AcAc2 as an anti-seizure medication, future
experiments should be carried out to verify if it is possible to obtain
an anti-seizure effect without any calorie restriction by trying to
administer this compound in a different way, such as mixed with
the food pellets or as a different, water-soluble pharmaceutical
preparation of the active ingredient (ketone mineral salt). BD-
AcAc2 did not show toxic effects on liver, kidney, stomach, or
neurological functions. Minor abnormal histological ﬁndings were
reported in two BD-AcAc2 -treated rats and in two water-treated
rats, thus these effects were unlikely caused by BD-AcAc2; further
studies on a larger number of observations are needed to
eventually prove a correlation between BD-AcAc2 and kidney
pathologies. However, the administration of BD-AcAc2 produced a
partial but signiﬁcant anorectic effect; thus, the general tolerability
of this pharmaceutical preparation, at least in terms of palatability,
is unlikely better than that of KD. A smaller dose could be more
tolerable, but further studies should verify if an anti-seizure effect
persists, given that even the dose used in the present experiment
did not cause a 24 h elevation in blood ketones (Fig. 3). This isanother reason for trying different, more palatable pharmaceutical
preparations, like a water soluble ketone salt.
The anti-seizure effect seen in all calorie restriction conditions
in these experiments agrees with previous ﬁndings in young rats
[6]; some authors even suggest that calorie restriction could be the
key factor in the anti-seizure effect [9]. Actually, there were many
historical reports noting an effect for calorie-restriction, and in
particular for fasting, since the Hippocratic collection; in the
modern era, this notion was ﬁrst drawn to the attention of the
scientiﬁc community by H. Rawle Geyelin [10,11]. In present days,
calorie-restriction is still acknowledged for having many positive
effects on longevity, diabetes, hypertension, cardiovascular dis-
ease, and cancer [12], in addition to representing a concrete anti-
epileptic resource [13]. It has been proposed that calorie restriction
produces an increase in GABA synthesis [14], a scavenging of
glutamate from brain to blood [15] and an increased activity of
AMP-activated protein kinase [16]; nevertheless, the mechanism
by which calorie restriction produces anti-seizure effects has still
to be clariﬁed.
In conclusion, from the present results three objectives emerge
for future research: (1) to ameliorate animal models that mimic
modern clinical dietary treatments, i.e. calorie restriction without
growth impairment; (2) to ﬁnd in vivo speciﬁc anti-seizure effects
of ketone bodies alone; (3) to formulate more tolerable synthetic
ketone bodies supplementations.
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